Article info

Download PDFPDF

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Authors

  • Nicola Flaum Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UKNorth West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Emma J Crosbie Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UKDivision of Gynaecology, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Emma Roisin Woodward Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Fiona Lalloo Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Robert Morgan The Christie NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Neil Ryan The Academic Women’s Health Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK PubMed articlesGoogle scholar articles
  • D Gareth Evans Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UKNorth West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKThe Christie NHS Foundation Trust, Manchester, UKPrevention Breast Cancer Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Manchester, UKManchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nicola Flaum; nicola.flaum{at}manchester.ac.uk
View Full Text

Citation

Flaum N, Crosbie EJ, Woodward ER, et al
MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Publication history

  • Received November 14, 2022
  • Accepted December 22, 2022
  • First published March 9, 2023.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.